Dea Belazi
AscellaHealth, a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance the quality of life for patients with complex, chronic conditions, is pleased to announce Dea Belazi, CEO and co-founder, AscellaHealth, is recognized as a PM360 Elite 100 Winner as a Transformational Leader in the tenth annual Elite 100. Belazi will be honored at the ELITE 100 Awards event on June 18th in New York City. All of the 100 winners are profiled in PM360’s May 2024 issue.
“This honor truly belongs to the entire AscellaHealth team in recognition of their expertise, dedication and ongoing work that enables patients with complex, chronic conditions to access specialty pharmaceuticals and novel therapies that enhance clinical outcomes,” says Belazi. “It is gratifying to lead a group of talented professionals who share my commitment to healthcare transformation and improving the processes for getting critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma.”
The ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people and teams in the healthcare and life sciences industries based on their career accomplishments. Out of more than 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry. Nominees for the award are evaluated based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts.
